Zennova Pharmaceuticals(chengdu)co.,Ltd

Zennova Pharmaceuticals (Chengdu) Co., Ltd, established in 2018, is a globally operating manufacturer offering comprehensive CMO and CRDMO-plus-sales services from facilities in the US and China, with sales channels spanning more than 30 countries. Its 35,000-square-meter Chengdu facility houses an advanced solid oral dosage production line with annual capacity for 4 billion tablets and capsules, certified by both the US FDA and China's NMPA, supporting partners through drug development, manufacturing, and global sales and marketing to meet FDA, EU EMA, and other international regulatory standards. Led by a management team with more than a century of combined US pharmaceutical experience across oral solid, soft gel, injectable, eye-drop, and other dosage forms, the company holds patents on its BioCarier and Liquipauls technology platforms, which are FDA-endorsed and designed for BCS Class IV, low-solubility, low-permeability drug molecules. Focused currently on the North American market with nervous system preparations and logistics support, the company offers OEM, ODM, and own-brand production and competes on brand recognition, international certification, experienced R&D personnel, and production capacity.